Compare ARVN & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARVN | CBNK |
|---|---|---|
| Founded | 2015 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.2M | 560.3M |
| IPO Year | 2018 | 2018 |
| Metric | ARVN | CBNK |
|---|---|---|
| Price | $9.29 | $36.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 2 |
| Target Price | $15.05 | ★ $35.50 |
| AVG Volume (30 Days) | ★ 898.7K | 47.3K |
| Earning Date | 05-04-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.52% |
| EPS Growth | 58.84 | ★ 60.85 |
| EPS | ★ 1.70 | 1.60 |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | $16.20 |
| Revenue Next Year | N/A | $8.52 |
| P/E Ratio | ★ $5.51 | $22.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.97 | $26.40 |
| 52 Week High | $14.22 | $38.83 |
| Indicator | ARVN | CBNK |
|---|---|---|
| Relative Strength Index (RSI) | 58.81 | 48.16 |
| Support Level | $7.90 | $34.40 |
| Resistance Level | $9.65 | $36.71 |
| Average True Range (ATR) | 0.36 | 0.65 |
| MACD | 0.04 | -0.25 |
| Stochastic Oscillator | 73.65 | 27.44 |
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage. The company generates majority revenue from the Commercial bank sector. Commercial Banking division focuses on providing personalized service to commercial clients throughout the operations supplemented by lending outside primary market as well as engaging in government guaranteed lending on a national basis.